We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
GLOBETECH PUBLISHING LLC

Download Mobile App





Portable Air Filters Effectively Remove SARS-CoV-2 Particles from Hospital Air in COVID-19 Surge Units

By HospiMedica International staff writers
Posted on 04 Nov 2021

In the world’s first live study, researchers have demonstrated that using a combination of science and engineering, COVID-19 aerosols and other microbial bioaerosols can be removed from the environment. More...

The study by researchers at Addenbrooke’s Hospital (Cambridge, UK) confirmed the efficacy of MAXVAC’s (Zurich, Switzerland) Medi 10 range of COVID busting mobile air purifiers. The theory behind the science was accepted, that the Medi successfully traps & kills the COVID virus, but up until very recently, no published trials had been carried out with COVID itself (just lookalike viruses).

The key to the success of the Medi has been a combination of science and engineering. The science was to refine a sequence of filters and UV-C light that could trap and kill the virus. This was achieved with the development of high flow Alpaire HEPA filters and advanced Steribreeze UV-C technology to clean air fast. The engineering was to put this science in an effective compact and secure mobile unit that was easy to use and capable of maintaining the cleaning of very high volumes of air fast. High airflow rates are very important so that the recommended air change scan be achieved, and more air is cleaned of the virus.

“We have worked closely with a number of hospitals, universities, schools & councils in the past two years and are thrilled that our Medi units have received yet another endorsement especially from such a prestigious research hospital as Addenbrookes,” said Neil Parsons, MAXVAC UK representative. Our goal at MAXVAC remains to continue to find solutions to make our working & living environments safer, and the Medi’s are part of that journey.”

Related Links:
Addenbrooke’s Hospital
MAXVAC 


Gold Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
New
Lateral Lumbar Interbody Spacer
CALIBER-L
New
Hemostatic Agent
HEMOBLAST Bellows
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Critical Care

view channel
Image: Researchers have taken a major step toward cuff-free blood pressure monitoring (Photo courtesy of Gwyneth Moe/Boston University)

Cuff-Free Blood Pressure Monitoring Device to Improve Early Detection and Management of Hypertension

Hypertension affects nearly half of all adults in the U.S. and remains the leading cause of cardiovascular disease. Regular and accurate blood pressure monitoring is essential for managing this condition,... Read more

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: A research collaboration aims to further advance findings in human genomics research in cardiovascular diseases (Photo courtesy of 123RF)

Bayer and Broad Institute Extend Research Collaboration to Develop New Cardiovascular Therapies

A research collaboration will focus on the joint discovery of novel therapeutic approaches based on findings in human genomics research related to cardiovascular diseases. Bayer (Berlin, Germany) and... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.